News & Press: Latest News

MDMA Statement on the “STRONGER Patents Act”

Tuesday, March 20, 2018  
Share |

MDMA Statement on the “STRONGER Patents Act”

Washington, D.C. – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding introduction of the “STRONGER Patents Act” in the United States House of Representatives:

MDMA applauds Congressmen Steve Stivers and Bill Foster for introducing bipartisan legislation that promotes innovation and intellectual property.

“The ‘STRONGER Patents Act’ provides a balanced approach to protect the work of innovators and entrepreneurs, and ensures that bad actors do not misuse our nation’s patent system.   According to a recent study by the U.S. Chamber of Commerce, the United States currently ranks 12th in the world in offering patent protections for inventors, and this legislation would bolster our nation’s ability to compete in the global marketplace and remain the leader in medical technology innovation.

“We look forward to working with Congress and all policy makers to strengthen the medical technology ecosystem so it can continue to foster the cures and therapies of tomorrow for patients and providers.”